Almost exactly 50 years ago, the first conference to consider breathlessness as a symptom was convened in Manchester by cardiorespiratory physicians and scientists. Julius Comroe identified that breathlessness not only comprised the sensation itself but also 'the patient's reaction to that sensation' and highlighted its similarity to pain in this regard. 1 Since that first historic meeting, progress in the clinical assessment and palliation of pain has been significant, while the chronic refractory breathlessness of advanced disease is still often overlooked; even when detected, it is imperfectly managed, causing unnecessary suffering. We suggest that, in part, this relates to a poor understanding of its underlying neurophysiology -on which the rationale, for a palliative care approach to symptom management, is based.
Comroe's insight into breathlessness as a central nervous system (CNS) phenomenon, and one with both sensory and affective dimensions, was prescient and has now been authoritatively confirmed in neuroimaging studies. 2, 3 It has been firmly established that breathlessness is a complex experience of the mind and the body, comprising different sensations that can only be perceived by the individual. Affective components drive the accompanying feelings of distress, fear and anxiety, and it is the brain, not the lungs, that generates these phenomena.
While the brain has long been recognised as the origin of all sensory phenomena, including breathlessness, in the neuroscientific literature, this insight has not yet been widely integrated into clinical approaches to the symptom. In cardiorespiratory and even palliative medicine, breathlessness is more commonly understood to be mediated in and by the heart, lungs and great vessels. 'Stimulation of the failing organ' is often considered the most effective intervention. 4 When this fails, little else is tried, and patients and families continue to live with this devastating symptom unrelieved.
When there was no evidence to guide clinicians, this could have been excusable. Now, however, the evidence base in the palliation of breathlessness is growing rapidly. The essence of palliative care is to improve patients' and carers' quality of life through early identification and impeccable assessment and treatment of symptoms. Palliative care clinicians and researchers therefore need to take the lead in improving the care of breathlessness, as they did with cancer pain, in every setting in collaboration with their colleagues, particularly those in cardiorespiratory medicine and primary care. The recent publication of two palliative medicine randomised controlled trials (RCTs) from specialist services in Cambridge and London, United Kingdom, demonstrating the effectiveness of a complex intervention in relieving suffering and reducing the impact of breathlessness, gives clinicians and commissioners the evidence they need to implement best practice. 5, 6 They emphatically remove any excuse for failing breathless patients, and their families, any longer.
'Assessing dyspnoea is the first step in managing it'. 7 There is clear evidence that although breathlessness is a very common symptom in advanced illness, its presence and severity are rarely recorded -even in diseases like cancer and chronic obstructive pulmonary disease (COPD) where it occurs in the majority of people. In the past, inadequate tools for assessing breathlessness in clinical practice, coupled with a sense of therapeutic nihilism, were probably contributory factors to this neglect. Now eliciting the presence of breathlessness, recording its severity and treating it should be standard practice. Importantly, increased understanding of the multidimensional nature of breathlessness has led to the development of new accurate scales that assess the sensory and affective components of the sensation, and use of these, such as the Multidimensional Dyspnoea Profile, needs to become part of routine care in all settings. 8 Banzett et al. 9 describe breathlessness as the first 'vital symptom' alongside the traditional vital signs that impact patient outcomes. They have demonstrated that the routine recording of breathlessness severity in acute medical units is quick and easy, and that breathlessness severity has potential as a prognostic indicator of in-hospital mortality and other serious outcomes. Appreciation of the usefulness of breathlessness as an indicator of general disease severity, as well as a contributor to unscheduled use of hospital services, particularly acute admissions out of hours, should enhance the likelihood that breathlessness will become more widely assessed, although this alone would not necessarily lead to effective treatment.
The complex intervention used in the Cambridge and London trials of specialist breathlessness services is within the capability and budget of any specialist palliative care service. Outcome measures in both trials tested CNS phenomena -in Farquhar et al., 5 'distress due to breathlessness' was measured, and in Higginson et al.'s 6 group, 'sense of mastery' over breathlessness. Both interventions were similar, using a combination of predominantly nonpharmacological interventions -such as the hand-held fan, breathing techniques and anxiety reduction -which altered central perception of breathlessness and enhanced patients' and carers' sense of efficacy. Both offered individualised ways for patients and carers to manage the anxiety and distress associated with the symptom.
Part of the challenge facing palliative care is to disseminate, outside the boundaries of the specialty, the idea that modulating central perception of this sensation and helping patients manage their affective response to it are inherent to good medical practice and should occur in parallel with disease modification.
Advances in neuroimaging should make this task easier, as this technique demonstrates visually and objectively the cerebral basis of feelings and emotions. 10 Farquhar et al. 5 highlighted the importance of a broader palliative care approach, as well as delivery of specific interventions. It was clear that the way interventions were delivered was central to their effectiveness. Often, skills such as empathetic listening and individualised assessment, intrinsic to palliative care but considered the softer, unscientific side of medicine, are dismissively characterised as a 'placebo effect'. Neuroimaging is enabling us to understand that 'feelings are mental experiences of body states … that signify physiological need'. 11 Some researchers go further, postulating that chronic complex symptoms, like breathlessness, centre on 'pathologies of feeling'. Other work is elucidating the neurophysiological basis of empathy and the neurobiological entity currently called the 'placebo effect', rich sources of further insight into the central role of the brain. 12, 13 Controlled trial evidence on the effectiveness of nonpharmacological interventions, allied with advances in neuroimaging and related disentangling of the complex neurophysiology, is allowing the generation of a clearly scientific rationale for this effective palliative care approach, helping it to be more widely understood and implemented. New service models will need to be researched and developed in collaboration with clinicians in cardiorespiratory medicine to make this new approach available to all who need it. 14 Fallon and Foley 15 have previously highlighted that extrapolation from research and clinical service work with patients with cancer may not provide optimal care for patients with non-malignant disease. The numbers of people suffering from breathlessness also make it impossible for palliative care services to fulfil this role. Meeting the needs of the millions of people who live with breathlessness, directly or indirectly, at a time when healthcare budgets are under severe pressure will require open-minded clinical and research collaboration.
The richness and potential of a fully interdisciplinary approach was demonstrated at a recent meeting of the Breathlessness Research Interest Group (BRIG) in Cambridge, United Kingdom, where attendees from various backgrounds, including respiratory medicine, anaesthetics, medical humanities, engineering and palliative care, assembled to discuss the many dimensions of current and future breathlessness research. Future efforts in this area will require even more ambitious interdisciplinary programmes that explore themes in-depth and longitudinally, evaluating both science and service delivery. The Wellcome Trust-funded 'Life of Breath' project introduced at the BRIG meeting is an exemplar -promising to broaden breathlessness horizons significantly. It aims to explore the phenomenology of breathing and breathlessness, by combining a medical humanities approach with clinical research, to influence the ways in which future research should be carried out. 16 It is hoped that this project will set a precedent for funders to consider investment in broad research collaborations, to return to Coats' early call for 'multiple approaches to amelioration' of breathlessness. 4 It will be exciting to see how future research develops, how growing collaboration can accelerate neurophysiological insight and, importantly, how this can translate into benefits for the many patients suffering from this debilitating symptom, which remains an enigma and a challenge to palliate.
